Biosyent (TSXV:RX) Cash Flow for Dividends : C$-2.08 Mil (TTM As of Dec. 2024)

View and export this data going back to 1979. Start your Free Trial

What is Biosyent Cash Flow for Dividends?

Biosyent's cash flow for dividends for the three months ended in Dec. 2024 was C$-0.51 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was C$-2.08 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Biosyent's quarterly payment of dividends stayed the same from Jun. 2024 (C$-0.52 Mil) to Sep. 2024 (C$-0.52 Mil) but then declined from Sep. 2024 (C$-0.52 Mil) to Dec. 2024 (C$-0.51 Mil).

Biosyent's annual payment of dividends increased from Dec. 2022 (C$-0.48 Mil) to Dec. 2023 (C$-1.91 Mil) and increased from Dec. 2023 (C$-1.91 Mil) to Dec. 2024 (C$-2.08 Mil).

Biosyent Cash Flow for Dividends Historical Data

The historical data trend for Biosyent's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Cash Flow for Dividends Chart

Biosyent Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-0.48

-1.91

-2.08

Biosyent Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-0.47	-0.52	-0.52	-0.52	-0.51

Biosyent Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.08 Mil.

Biosyent Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Biosyent's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyent Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

BIOYF:USA

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Executives

Peter Douglas Lockhard	Director
Blair Driscoll	10% Security Holder
Merrilyn Joy Driscoll	10% Security Holder
Sean Driscoll	10% Security Holder
Fax Capital Corp.	10% Security Holder
Fax Investments Inc.	10% Security Holder
Federated Capital Corp.	10% Security Holder
Seyed Ahmad Ashrafi	Director
Robert Joseph March	Senior Officer
Sharan Raghubir	Senior Officer
Rene Goehrum	10% Security Holder, Director, Senior Officer
Biosyent Inc.	Issuer
Joost Van Der Mark	Senior Officer
Sara Elford	Director
Alfred D'souza	Director

Biosyent Headlines

No Headlines